In the News: Nov 8–15
By Sg2 TeamThis week: Liquid biopsy tests for cancer care move into the mainstream; midterm elections prove consequential to Medicaid; and CVS Health to expand services into chronic disease management.
- Share
This week: Liquid biopsy tests for cancer care move into the mainstream; midterm elections prove consequential to Medicaid; and CVS Health to expand services into chronic disease management.
Primary care is being reinvented, with most past successes and future promises coming from Medicare Advantage, where success managing chronic populations yields economic benefits. Read on to learn more.